- Home
- CMPO vs COLL Comparison
CMPO vs COLL Comparison
Compare CMPO & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPO
- COLL
- Stock Information
- Founded
- CMPO 2000
- COLL 2002
- Country
- CMPO United States
- COLL United States
- Employees
- CMPO N/A
- COLL N/A
- Industry
- CMPO Finance: Consumer Services
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- CMPO Finance
- COLL Health Care
- Exchange
- CMPO Nasdaq
- COLL Nasdaq
- Market Cap
- CMPO 1.1B
- COLL 864.7M
- IPO Year
- CMPO N/A
- COLL 2015
- Fundamental
- Price
- CMPO $11.58
- COLL $28.89
- Analyst Decision
- CMPO Strong Buy
- COLL Strong Buy
- Analyst Count
- CMPO 8
- COLL 5
- Target Price
- CMPO $16.19
- COLL $43.80
- AVG Volume (30 Days)
- CMPO 554.5K
- COLL 325.8K
- Earning Date
- CMPO 05-12-2025
- COLL 05-08-2025
- Dividend Yield
- CMPO 2.16%
- COLL N/A
- EPS Growth
- CMPO N/A
- COLL N/A
- EPS
- CMPO N/A
- COLL 1.25
- Revenue
- CMPO $420,571,000.00
- COLL $664,283,000.00
- Revenue This Year
- CMPO $7.26
- COLL $19.96
- Revenue Next Year
- CMPO $8.20
- COLL $3.93
- P/E Ratio
- CMPO N/A
- COLL $23.01
- Revenue Growth
- CMPO 7.67
- COLL 17.17
- 52 Week Low
- CMPO $4.97
- COLL $23.23
- 52 Week High
- CMPO $14.71
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- CMPO 61.18
- COLL 59.59
- Support Level
- CMPO $10.82
- COLL $26.72
- Resistance Level
- CMPO $11.53
- COLL $27.70
- Average True Range (ATR)
- CMPO 0.32
- COLL 1.02
- MACD
- CMPO 0.11
- COLL 0.24
- Stochastic Oscillator
- CMPO 91.11
- COLL 79.71
About CMPO CompoSecure Inc.
CompoSecure Inc is engaged in designing and manufacturing premium financial cards. The Company's metal payment card technology and Arculus security and authentication capabilities deliver premium branded experiences which enable people to access and use their assets, and ensure trust at the point of a transaction. Its products include Metal Cards and Arculus, a digital security platform. It has two reportable segments: Payment Card and Arculus.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.